Investor FAQs

Where is Aytu BioPharma’s corporate headquarters?

On what stock exchange are Aytu BioPharma’s shares traded and what is the ticker?

Aytu BioPharma’s stock is traded on the Nasdaq Capital Market under the ticker AYTU

Who is Aytu BioPharma’s transfer agent?

Direct Transfer, LLC
1 Glenwood Ave.
Suite 1001
Raleigh, NC 27603

Who should I contact with questions about my stock?

Direct Transfer, LLC
1 Glenwood Ave.
Suite 1001
Raleigh, NC 27603

Does Aytu BioPharma have a direct stock purchase plan?

The Company does not currently have a direct stock purchase plan. The Company’s common stock can be purchased by contacting a securities broker of your choice.

Who is Aytu BioPharma’s legal counsel?

Dorsey & Whitney, LLP
1400 Wewatta Street
Suite 400
Denver, CO 80202-5549
303-629-3400

Who is Aytu BioPharma's independent auditor?

Grant Thornton LLP
1801 California St.
Suite 3700
Denver, CO 80202
D +1 303 813 4000
F +1 303 839 5711

How can I get the latest corporate news and financial reports?

Corporate news can be found in the Press Releases section of our Investors webpage. Quarterly and annual reports, as well as other SEC filings, can be found in the SEC Filings section of our Investors webpage or directly from the SEC at www.sec.gov.

Who should I contact if I have a question or request about Aytu BioPharma?

Please contact investors@aytubio.com with any additional inquiries

How can I obtain a copy of your annual report and proxy?

The Company’s annual report on Form 10K can be found under the SEC Filings section of our Investors webpage or directly from the SEC at www.sec.gov.